Approval · Notice of Compliance 1789 · 2003
METHOTREXATE: Notice of Compliance 1789
Issued December 5, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1789
- Date
- December 5, 2003
- Company
- Mayne Pharma (Canada) Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimetabolite and antirheumatic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | 02182750 | Marketed |
Medicinal ingredients
- METHOTREXATE 10 MG per TAB